- Home
- SGU vs CLLS Comparison
SGU vs CLLS Comparison
Compare SGU & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SGU | CLLS |
|---|---|---|
| Founded | 1995 | 1999 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 431.4M | 394.4M |
| IPO Year | 1997 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SGU | CLLS |
|---|---|---|
| Price | $12.97 | $1.08 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $4.83 |
| AVG Volume (30 Days) | 22.8K | ★ 98.3K |
| Earning Date | 12-07-2026 | 11-10-2026 |
| Dividend Yield | ★ 6.12% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $1,784,418,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.70 |
| P/E Ratio | $6.70 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.41 | $0.88 |
| 52 Week High | $13.53 | $5.45 |
Technical Indicators
Market Signals| Indicator | SGU | CLLS |
|---|---|---|
| Relative Strength Index (RSI) | 52.25 | 38.78 |
| Support Level | $12.36 | $0.88 |
| Resistance Level | $13.20 | $2.99 |
| Average True Range (ATR) | 0.20 | 0.10 |
| MACD | -0.01 | 0.07 |
| Stochastic Oscillator | 52.50 | 57.67 |
Price Performance
Historical ComparisonAbout SGU Star Group L.P.
Star Group LP is a home heating oil and propane distributor and services provider with one reportable operating segment that principally provides heating related services to residential and commercial customers. It serves residential and commercial customers whose primary use is to heat their homes and buildings in the Northeast and Mid-Atlantic U.S. regions. The company derives the majority of revenue from Petroleum products, which consist of home heating oil and propane as well as diesel fuel and gasoline.
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.